Vulnerability to opiate intake in maternally deprived rats: Implication of MeCP2 and of histone acetylation

Addiction Biology

Volumn 20, Issue 1, 2015, Pages 120-131

  Tesone Coelho, Carolina ^a   Morel, Lydie J ^b,c,d   Bhatt, Jeena ^b,c,d   Estevez, Lucie ^b,c,d   Naudon, Laurent ^b,c,d   Giros, Bruno ^b,c,d,e   Zwiller, Jean ^a   Daugé, Valérie ^b,c,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

HDAC; histone acetylation; maternal deprivation; MeCP2; morphine consumption; sodium valproate

Indexed keywords

HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; HISTONE H4; METHYL CPG BINDING PROTEIN 2; MORPHINE; VALPROIC ACID; HDAC2 PROTEIN, RAT; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MECP2 PROTEIN, RAT; NARCOTIC ANALGESIC AGENT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG USE; FEMALE; HISTONE ACETYLATION; IMMUNOHISTOCHEMISTRY; MALE; MATERNAL DEPRIVATION; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ACETYLATION; ANIMAL; ANIMAL BEHAVIOR; GENETIC EPIGENESIS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; METABOLISM; OPIATE ADDICTION;

ACETYLATION; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; MATERNAL DEPRIVATION; METHYL-CPG-BINDING PROTEIN 2; MORPHINE; NUCLEUS ACCUMBENS; OPIOID-RELATED DISORDERS; RATS; VALPROIC ACID;

EID: 84919873526     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12084     Document Type: Article

References (50)

1. Akhtar MW, Raingo J, Nelson ED, Montgomery RL, Olson EN, Kavalali ET, Monteggia LM, (2009) Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci 29: 8288-8297.
2. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY, (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
3. Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ, (2007) Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 31: 47-58.
4. Calfa G, Percy AK, Pozzo-Miller L, (2011) Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) 236: 3-19.
5. Caprioli D, Celentano M, Paolone G, Badiani A, (2007) Modeling the role of environment in addiction. Prog Neuropsychopharmacol Biol Psychiatry 31: 1639-1653.
6. Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J, (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70: 487-492.
7. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY, (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229.
8. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ, (2006) Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 147: 2909-2915.
9. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME, (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889.
10. Covington HE, 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ, (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29: 11451-11460.
11. Daugé V, (2013) Preclinical animal studies: opiates. In:, Miller PM, ed. Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders, pp. 141-148. Elsevier Inc., Academic Press.
12. Deng JV, Rodriguiz RM, Hutchinson AN, Kim IH, Wetsel WC, West AE, (2010) MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat Neurosci 13: 1128-1136.
13. Franklin TB, Russig H, Weiss IC, Graff J, Linder N, Michalon A, Vizi S, Mansuy IM, (2010) Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry 68: 408-415.
14. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T, (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278: 4035-4040.
15. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH, (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459: 55-60.
16. Hall FS, (1998) Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences. Crit Rev Neurobiol 12: 129-162.
17. Host L, Dietrich JB, Carouge D, Aunis D, Zwiller J, (2011) Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J Psychopharmacol 25: 222-229.
18. Im HI, Hollander JA, Bali P, Kenny PJ, (2010) MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 13: 1120-1127.
19. Jing L, Luo J, Zhang M, Qin WJ, Li YL, Liu Q, Wang YT, Lawrence AJ, Liang JH, (2011) Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. Neurosci Lett 494: 169-173.
20. Kinnally EL, Feinberg C, Kim D, Ferguson K, Leibel R, Coplan JD, John Mann J, (2011) DNA methylation as a risk factor in the effects of early life stress. Brain Behav Immun 25: 1548-1553.
21. Klose RJ, Bird AP, (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97.
22. Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, Shinagawa T, Yasukawa T, Colmenares C, Ishii S, (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 276: 34115-34121.
23. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, Russo SJ, Laplant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ, (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48: 303-314.
24. Legastelois R, Botia B, Naassila M, (2013) Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. Alcohol Clin Exp Res 37: 1143-1153.
25. Li JX, Zhang Q, Liang JH, (2004) Valproate prevents the induction, but not the expression of morphine sensitization in mice. Behav Brain Res 152: 251-257.
26. Löscher W, (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58: 31-59.
27. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA, (2009) Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 67: 36-43.
28. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ, (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12: 342-348.
29. Miyake K, Hirasawa T, Soutome M, Itoh M, Goto Y, Endoh K, Takahashi K, Kudo S, Nakagawa T, Yokoi S, Taira T, Inazawa J, Kubota T, (2011) The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. BMC Neurosci 12: 81.
30. Morel LJ, Giros B, Daugé V, (2009) Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology 34: 2469-2476.
31. Mu P, Yu LC, (2007) Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. Neurosci Lett 426: 135-138.
32. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fischer D, Holsboer F, Wotjak CT, Almeida OF, Spengler D, (2009) Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12: 1559-1566.
33. Na ES, Monteggia LM, (2011) The role of MeCP2 in CNS development and function. Horm Behav 59: 364-368.
34. Nalivaeva NN, Belyaev ND, Turner AJ, (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30: 509-514.
35. Nan X, Campoy FJ, Bird A, (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.
36. Neisewander JL, Peartree NA, Pentkowski NS, (2012) Emotional valence and context of social influences on drug abuse-related behavior in animal models of social stress and prosocial interaction. Psychopharmacology (Berl) 224: 33-56.
37. Pastor V, Host L, Zwiller J, Bernabeu R, (2011) Histone deacetylase inhibition decreases preference without affecting aversion for nicotine. J Neurochem 116: 636-645.
38. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS, (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741.
39. Renthal W, Nestler EJ, (2008) Epigenetic mechanisms in drug addiction. Trends Mol Med 14: 341-350.
40. Repunte-Canonigo V, Chen J, Lefebvre C, Kawamura T, Kreifeldt M, Basson O, Roberts AJ, Sanna PP, (2013) MeCP2 regulates ethanol sensitivity and intake. Addict Biol Feb 28 [Epub ahead of print]. doi: 10.111/adb.12047.
41. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J, (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28: 9342-9348.
42. Sanchis-Segura C, Lopez-Atalaya JP, Barco A, (2009) Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 34: 2642-2654.
43. Shen HY, Kalda A, Yu L, Ferrara J, Zhu J, Chen JF, (2008) Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. Neuroscience 157: 644-655.
44. Tudor M, Akbarian S, Chen RZ, Jaenisch R, (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99: 15536-15541.
45. Vazquez V, Farley S, Giros B, Daugé V, (2005a) Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260. Psychopharmacology (Berl) 181: 706-713.
46. Vazquez V, Giros B, Daugé V, (2006) Maternal deprivation specifically enhances vulnerability to opiate dependence. Behav Pharmacol 17: 715-724.
47. Vazquez V, Penit-Soria J, Durand C, Besson MJ, Giros B, Daugé V, (2005b) Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood. J Neurosci 25: 4453-4462.
48. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, Szyf M, (2005) Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25: 11045-11054.
49. Wolden-Hanson T, Gidal BE, Atkinson RL, (1998) Evaluation of a rat model of valproate-induced obesity. Pharmacotherapy 18: 1075-1081.
50. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY, (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A 102: 17551-17558.